Tracon Pharmaceuticals Inc (TCON)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,588 | -29,135 | -28,667 | -16,775 | -22,674 |
| Depreciation Amortization | 7,359 | 505 | -39 | 29 | 45 |
| Other Working Capital | -2,152 | -239 | 4,545 | -1,579 | -2,879 |
| Other Operating Activity | 2,057 | 2,630 | 1,590 | 1,283 | 1,858 |
| Operating Cash Flow | $3,676 | $-26,239 | $-22,571 | $-17,042 | $-23,650 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | 4,000 | -3,998 | 14,020 |
| PPE Investments | N/A | -17 | -48 | -5 | N/A |
| Investing Cash Flow | $N/A | $-17 | $3,952 | $-4,003 | $14,020 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 13,390 | N/A | 0 | N/A |
| Debt Repayment | -20,500 | -1,680 | -2,800 | -1,400 | -1,400 |
| Common Stock Issued | 7,961 | 7,974 | 13,360 | 38,164 | 2,306 |
| Financing Cash Flow | $-12,539 | $19,684 | $10,560 | $36,764 | $906 |
| Beginning Cash Position | 17,500 | 24,072 | 32,131 | 16,412 | 25,136 |
| End Cash Position | 8,637 | 17,500 | 24,072 | 32,131 | 16,412 |
| Net Cash Flow | $-8,863 | $-6,572 | $-8,059 | $15,719 | $-8,724 |
| Free Cash Flow | |||||
| Operating Cash Flow | 3,676 | -26,239 | -22,571 | -17,042 | -23,650 |
| Capital Expenditure | N/A | -17 | -48 | -5 | 0 |
| Free Cash Flow | 3,676 | -26,256 | -22,619 | -17,047 | -23,650 |